Soon after we confirmed what we had already suspected: that developing a new pharmaceutical product is extremely complicated.
Another common example might involve an application for regulatory permission to market a new pharmaceutical, where there is an arguable error or even falsehood, but where the officer has no actual knowledge of the error or falsehood.
FORBES: "How a Floridian busted for cocaine possession may save future white collar defendants"
WebMD added that it expects an increase in the number of new branded pharmaceutical product introductions as a result of regulatory approvals expected during 2012.
FORBES: WebMD Ends Search For Buyer; CEO Out; Guide Weak; Shrs Off
In the first nine months of 2012 Kalbe launched 12 new prescription pharmaceutical products, apart from the products it is acquiring, says Danareska Securities analyst Mardesiana.
FORBES: Indonesia's Kalbe Farma Expands From Health Care To Juice Drinks and Beyond
The Fairfield, New Jersey pharmaceutical marketer is the parent company of Doak Dermatologics, which sells Keralac, a prescription skin softener, and Kenwood Therapeutics, which sells gastrointestinal medication.
Clark added the company's Clinical and Medical Products sector will be a key growth driver, and expects to benefit from new generic pharmaceutical launches and improvements in operational performance.
The agency must deal with about 110 new drug applications from pharmaceutical companies annually.
American Home Products, based in Madison, New Jersey, makes pharmaceutical products, including Advil pain reliever and Robitussin cough syrup.
BBC: News | The Company File | AHP and Monsanto call off merger
Pfizer (NYSE: PFE), the New York-based pharmaceutical company, reported third quarter earnings this morning that handily beat Wall Street analysts.
FORBES: One Pill Makes You Stronger: Pfizer Earnings Are the "White Knight"
The new campaign shows how pharmaceutical companies are trying to adapt the marketing of their products to a climate of hair-trigger concern over drug safety.
However, our leadership position may not last as increasingly onerous burdens posed by regulation of new developments, like the FDA approval process, in conjunction with billions of dollars in new taxes imposed on pharmaceutical manufacturers and medical device makers threaten to stall innovation.
One doctor group, the Infectious Diseases Society of America, calls for new incentives to lure big pharmaceutical companies back into the field.
Understanding how a gene contributes to a disease like cancer can help pharmaceutical companies develop new drugs to treat it.
Pharmaceutical companies devise new drugs for the conditions it defines, lawyers use it to sue doctors, ordinary people use it to diagnose themselves.
It leads the pharmaceutical industry in new drug approvals for the past two years, with four brand-new drug molecules approved in 2001 and five approved in 2000.
Nonetheless, the news might prompt new legislation aimed at the pharmaceutical industry, though it is not clear at this point what form, if any, a bill might take.
During the 1980s and '90s, Schering-Plough refined its focus on four key therapeutic areas and integrating new technologies to achieve important pharmaceutical advances in antihistamines, corticosteroids, antibiotics, anti-infectives and antiviral products.
As regards the dissemination of information about new drugs and devices, pharmaceutical companies are subject to increasingly stringent rules on the types of promotional practices that they can use to market their new products.
FORBES: Causing More Harm than Good: Conflict-of-Interest Rules Thwart Medical Progress
It will end up hurting the elderly and the rest of us by strangling the inventiveness and spirit of innovation that is leading to a fabulous array of new drug breakthroughs from our pharmaceutical companies.
Because generic companies tend to challenge patents of every successful drug, the FTC's position would impose onerous legal costs on brand-name drugmakers and limit their ability to fund expensive research to create new drugs, said the Pharmaceutical Research and Manufacturers of America, which represents brand-name drugmakers.
But the drug's success highlights how difficult it is for pharmaceutical firms to invent new medicines.
The move to buy Wyeth is the first in a new round of consolidation in the pharmaceutical industry, in what analysts expect will be a significant shrinking of the sector.
Last week the Guardian published a short extract from my new book about problems in the pharmaceutical industry, in which I talk at length about the problem of withheld clinical trial data.
FORBES: The Real Scandal Is Not Acknowledging That Drugs Do Work
The Obama administration has become so concerned about the slowing pace of new drugs coming out of the pharmaceutical industry that officials have decided to start a billion-dollar government drug development center to help create medicines.
At that moment a new firm might be spun out of the institute, or a deal might be done with an established pharmaceutical firm, to try to get a new drug developed.
To help pay for the improved benefits, the pharmaceutical industry will face a new tax.
FORBES: Seniors To See Improved Health Care Benefits In 2011
The administration's objections centre around the fear that inspections would compromise the necessary secrecy that surrounds legitimate pharmaceutical companies as they develop new commercial drugs.
L. Mencken, movie director Mike Nichols, New York Times publisher Adolph Ochs, pharmaceutical entrepreneur Charles Pfizer, architect Ludwig Mies van der Rohe, slugger Babe Ruth, cartoonist Charles M.
FORBES: Four Easy Ways For Republicans To Attract Immigrant Voters
It also drives home the trouble that large pharmaceutical companies are having inventing new medicines, even as their old moneymakers approach a time when they will no longer have patent protection.
"In filling this critical position, we looked for someone with experience both within and beyond the pharmaceutical industry who could bring new approaches and ideas to the company, along with a proven ability to drive change and growth, " Clark said in a statement at the time.
应用推荐